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1. INTRODUCTION 
 
Progress of modern intensive care medicine has made it possible to save more 
and more lives of critically ill patients. Nowadays we seldom have the patients 
not surviving the initial phase of illness. However, the development of multiple 
organ dysfunction syndrome (MODS) in the later course of the disease remains 
still a challenge for the caregivers and medical research. Adequate tissue per-
fusion and metabolism are mandatory for normal organ functioning. Hypo-
perfusion is the main reason for the MODS, which means that altered organ 
function is present in acutely ill patients so that homeostasis cannot be main-
tained without intervention. It usually involves two or more organ systems. 
MODS is a main cause of mortality in critically ill patients. Abdominal com-
partment syndrome (ACS) was first described as a phenomenon by Emerson in 
1911 by demonstrating an association between increased intra-abdominal 
pressure (IAP) and decreased central venous return (Emerson, 1911). Nowadays 
ACS is the well-known risk factor for the development of MODS. Intra- 
abdominal pressure (IAP) was first measured via the urinary bladder by Kron et 
al., 1984; they also concluded that an IAP above 25 mmHg and low urinary 
output are an indication for abdominal re-exploration and decompression (Kron 
et al., 1984). There are several hypotheses that attempt to explain the role of 
intra-abdominal hypertension (IAH) in the pathogenesis of MODS: one of them 
is the splanchnic hypoperfusion and the subsequent mucosal ischaemia cause 
structural changes and alterations in cellular function (Moore, 1999). This may 
result in increased gut permeability, altered immune function of the gut and 
increased translocation of bacteria (Deitch, 1989). 
Hypoperfusion is difficult to measure; one possibility is to observe the 
microcirculation by means of intravital microscopy. Another possibility is to 
measure the metabolism in the tissue of interest. Both techniques are described 
in experimental studies in animals and humans, but measuring hypoperfusion of 
splanchnic organs is still considered to be very invasive for routine clinical 
practice. Thus, some surrogate measuring sites have been proposed: sublingual 
microscopy for microcirculation and rectus abdominis muscle for metabolism 
measurements. 
The main aim of the present dissertation was to test the hypothesis that 
elevated IAP is associated with tissue hypoperfusion and the prevalence of 
anaerobic metabolism.  
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2. REVIEW OF THE LITERATURE 
 
2.1. Intra-abdominal hypertension 
Intra-abdominal hypertension (IAH), sustained or repeated pathological ele-
vation of the intra-abdominal pressure (IAP) above 12 mmHg, affects appro-
ximately one third of intensive care patients. Epidemiological studies have 
repeatedly shown that patients with IAH have impaired outcomes (Regueira et 
al., 2008; Santa Teresa et al., 2012; Reintam et al., 2008). Several clinical con-
ditions are associated with the increased risk of IAH (Kirkpatrick et al., 2013). 
Obesity, positive fluid balance abdominal surgery, and pancreatitis are the most 
commonly appearing indipendent risk factors in different studies (Holodinsky et 
al., 2013).  
Normal values for IAP in intensive care patients are between 5 and 7 mmHg 
(Kirkpatrick et al., 2013). The IAP is usually measured via a urinary bladder 
catheter, at end-expiration in the supine position (Malbrain, 2004), after instil-
lation of 25 ml of sterile saline into the bladder. The mid-axillary line is taken 
as a zero level for IAP readings (Malbrain, 2004) and, if required, patients are 
given bolus sedation/relaxation to avoid excessive pressure artefacts during 
measurements. On elevating the head of bed from 10 to 30 to 45 degrees, IAP is 
increased progressively (Yi et al., 2012), and therefore a full supine position is 
recommended for correct measurements. 
 
 
2.1.1. Abdominal perfusion pressure 
The abdominal perfusion pressure (APP), calculated as the difference between 
the mean arterial pressure (MAP) and the IAP (APP = MAP - IAP), determines 
the blood flow into abdominal organs and tissues Verdant et al., 2009; 
Cheatham et al., 2007). The APP is suggested to be the best predictor of patient 
outcome when compared with MAP, IAP, arterial pH, base deficit, arterial 
lactate or hourly urinary output (Cheatham et al., 2000). APP has been sug-
gested for use as a surrogate marker to assess haemodynamic changes related to 
IAH (Cheatham et al., 2000). A minimally sufficient level for APP is still not 
unequivocal; there have been suggestions to keep it at a level of above  
60 mmHg at least (Malbrain et al., 2006). The latest consensus definitions and 
clinical practice guidelines from the World Society of Abdominal Compartment 
Syndrome (WSACS), however, do not recommend using APP as the resusci-
tation or management endpoint because of the lack of a sufficient level of 
positive evidence (Kirkpatrick et al., 2013). 
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2.1.2 Consequences of IAH  
The effect of elevated IAP on end-organ function has been described repeatedly, 
both in experimental animals and in human studies. Among the earliest clinical 
signs of increased IAP are oliguria and renal dysfunction. Dalfino et al. showed 
that elevated IAP and low APP are factors that promote acute renal failure 
(ARF) in critically ill patients after shock (Dalfino et al., 2008). The risk of 
ARF is already increased at IAP levels above 12 mmHg (Dalfino et al., 2008; 
Mohmand & Goldfarb, 2011). The cardiopulmonary system is also frequently 
affected by IAH. Increased IAP leads to elevated diaphragms, raised intra-
thoracic pressures, decreased lung and chest wall compliance, and to hypoxia 
and hypercapnia as a result (Vegar-Brozovic et al., 2008). Its direct com-
pression of the heart and the vena cava system elevates venous pressures and 
decreases heart volumes (Carlotti & Carvalho, 2009). Elevated venous pressure 
and increased intrathoracic pressure cause a secondary increase in intracranial 
pressure because of obstruction of the cerebral venous blood outflow. Therefore 
IAH can lead to brain oedema and ischaemia and subsequent brain deterioration 
and damage (Vegar-Brozovic et al., 2008).   
Few data are available on splanchnic perfusion and gut microcirculation in 
connection with elevated abdominal pressures. In an animal model of IAH, 
Moore-Olufemi et al. showed that an increased IAP of 20 to 25 mmHg leads to 
gut oedema in spite of intact lymphatics (Moore-Olufemi et al., 2005). Doty et 
al. investigated whether IAH causes bacterial translocation through the gut 
mucosal barrier in pigs. Bacterial translocation was not convincingly proven, 
but significant gut mucosal acidosis and ischaemia were found to be caused by 
high levels (up to 30 mmHg) of IAP (Doty et al., 2002) 
There are also some studies indicating involvement of cytokines in the fatal 
cascade leading to multiple organ failure in IAH (Avraamidou et al., 2012; 
Rezende-Neto et al., 2002). Whether IAH has an impact on the microcirculation 
is not known. The present thesis addresses this question. 
 
 
2.1.3. Severity of IAH 
According to its severity, IAH is graded into four levels. Grade I refers to IAP 
levels from 12 to 15 mmHg, Grade II 16 to 20, Grade III 21 to 25 and Grade IV 
above 25 mmHg, respectively. The most severe form of IAH is abdominal 
compartment syndrome (ACS). ACS is a life-threatening syndrome, defined as 
a sustained IAP ≥ 20 mmHg (with or without an APP of ≤ 60 mmHg) as-
sociated with a new onset or worsening of existing organ failure (Malbrain et 
al., 2006). The reported prevalence of ACS varies from 1 to 12%, depending on 
the study population (Vidal et al. 2008; Malbrain et al. 2005). Higher incidence 
has been reported in trauma and burns (Balogh et al., 2003; Balogh et al., 2003; 
Tuggle et al., 2007), while our studies in mixed critically ill patients have 
shown an incidence of approximately 2% (Reintam Blaser et al., 2013; Reintam 
Blaser et al., 2011; Maddison et al., 2009; Reintam et al., 2008). Awareness and 
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treatment of ACS has been addressed more and more frequently (Carr, 2013; 
Kirkpatrick et al., 2013) and, as a result, the incidence and mortality have 
decreased about twofold in the last decade (Carr, 2013; Reintam Blaser et al., 
2013).  
In contrast to ACS, the consequences of IAH grade I and II are not uni-
formly understood and treatment recommendations are either absent or 
imprecise. At the same time, most intensive care patients suffering from IAH 
express IAP levels between 12 and 18 mmHg, i.e., IAH Grades I and II 
(Malbrain et al., 2013). The present work was undertaken first of all to address 
the tissue perfusion and metabolism at the lower grades of IAH. We hypo-
thesized that even a moderate increase in IAP attenuates vascular perfusion in 
the abdominal area with consequent disturbances in tissue metabolism. This 
might explain the development of organ dysfunction later in the course of IAH.  
 
 
2.1.4. IAH during laparoscopic surgery 
During laparoscopic surgery pneumoperitoneum is generated by insufflation of 
CO2; as a result, IAP is elevated above the normal level. The European Practice 
Guidelines for Pneumoperitoneum in laparoscopic surgery state that IAP levels 
higher than 12 mmHg should be avoided and that the duration of the procedure 
must be kept as short as possible (Neudecker et al., 2002). Still, pneumoperi-
toneum serves as an excellent model for investigating the effects of mild and 
relatively short-time IAH on patients. 
 
 
2.2. Microcirculation and IAH 
2.2.1. Importance of microcirculation 
The microcirculation is that part of the organism’s circulation in which oxygen, 
nutrients and other substances are exchanged between the circulating blood and 
parenchymal cells (Ince, 2005). Adequate blood flow in capillaries is mandatory 
for normal organ perfusion and functioning (den Uil et al. 2008). In different 
critical conditions, an aggressive correction of volume status, perfusion pres-
sures and cardiac output (CO) by means of volume resuscitation and vasoactive 
agents is the primary therapy. Still, we observe the cases where patient dies 
despite of clear improvement in MAP, arterial lactate, and/or venous oxygen 
saturation levels. Research on microcirculation has repeatedly demonstrated 
weak correlations of macrocirculatory indices (CO, MAP) with ones from 
micovasculatory beds (vascular density, proportion of perfused microvessels 
(PPV), etc.)(De Backer et al., 2010). Further, recently De Backer and co-
workers demonstrated that characteristics of microcirculation are independent 
prognostic factors of outcome in critical conditions, especially in septic shock 
(De Backer et al., 2013). On that background it has been suggested that micro-
circulatory indices (PPV, microvascular flow index (MFI), etc.) rather than 
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macrocirculatory parameters (blood pressure, heart rate, urine output) should be 
used as an endpoint in shock resuscitation (Trzeciak et al., 2008; De Backer et 
al., 2013). 
The practical problem in such approach, however, is the reliability of the 
methodology for the bed-side assessment of microcirculation. The sublingual 
region is the most readily accessible mucosal area in humans. The blood supply 
comes from the external carotid artery – lingual artery – sublingual artery. Only 
a limited number of sublingual arterioles are present, but there are many 
capillaries and venules.  
 
 
2.2.2. Visualisation of microcirculation 
In experimental cases, the intravital microscopy is regarded as the golden stan-
dard for visualization of microcirculation (Cerny, 2012). This technique makes 
it possible to investigate thin tissues that allow transillumination and requires 
fluorescent dyes (den Uil et al., 2008); therefore, it is not applicable to humans.  
In clinical settings, several methods are used to assess the microcirculation. 
For a long time, capillary microscopy was the only method available to assess 
the human microcirculation. The main disadvantage was the usage of this 
technique only in restricted surfaces such as the skin or nailfold (Cerny, 2012). 
Laser-Doppler flowmetry is also an option, but it provides the flow charac-
teristics only for local situation (den Uil et al., 2008). The human micro-
circulation can be visualized directly with various videomicroscopes: the first-
generation device used orthogonal polarization spectral (OPS) imaging, then a 
more advanced device was produced – the sidestream dark field (SDF) imaging 
device and now the latest development of the Braedius cytocam. The main 
principle of these devices is basically the same, but the image quality has 
improved significantly with every new development. The most studied site is a 
sublingual microcirculation, but the microcirculation can be studied in different 
organs and tissues covered with an epithelial layer, and also in the micro-
circulation in the skin of preterm babies.  
A schematic representation of the SDF is shown in Figure 1. Captured 
images are saved for later analysis.  
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Figure 1. SDF imaging. (a) SDF imaging consists of a light guide surrounded by green 
light-emitting diodes (LEDs; wavelength 530 nm) whose light penetrates the tissue and 
illuminates the microcirculation. The light is absorbed by haemoglobin in the red blood 
cells and scattered by leucocytes. A magnifying lens projects the image onto a video-
camera. Placed on organ surfaces, SDF imaging provides images of the red blood cells 
and leucocytes flowing through the microcirculation. (b) An example of the image 
quality provided by SDF imaging. (From Ince, 2005 with the permisson from BioMed 
Central; Critical Care). 
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2.2.3. Microcirculation, shock and multiple organ failure  
Shock refers to the life-threatening medical condition characterised by inade-
quate oxygen transport to the tissues. As microcirculation is the part of vascular 
bed where gas exchange between blood and tissues occurs, one may consider 
the shock as a disorder of microcirculation. It has been shown that in early 
phases of sepsis, a persistent microcirculatory deficit is associated with a poor 
outcome (De Backer, 2002), and there are several pathogenic mechanisms 
which affect the microcirculation.  
During the septic shock there is a cascade of pathophysiological mechanisms 
which lead to microcirculatory failure. The leukocytes and red blood cells 
normal functioning is disturbed (Eppihimer & Lipowsky 1994; Baskurt et al., 
1998). Circulating inflammatory mediators cause vasodilatation and endothelial 
injury which leads to capillary leakage. The heterogeneous shutdown of capil-
laries occurs because of vasodilatation and endothelial injury (Ince & Sinaas-
appel 1999). When global flow returns after fluid resuscitation, the micro-
circulation becomes even more heterogeneous, probably because of inflam-
matory response associated with reperfusion (DeBacker 2010). Increased 
heterogeneity results in severe tissue hypoxia and decreased oxygen extraction 
(Klijn et al., 2008).  
The microcirculatory changes in sepsis can occur in the presence of normal 
systemic haemodynamics. On the other hand, in hypovolemic shock, the micro-
circulation and systemic haemodynamics seem to follow each other more 
closely (De Backer et al., 2010). The difference is probably in the fact that 
autoregulatory mechanisms are still functioning in hypovolemic shock but not 
in sepsis (Klijn et al., 2008).  
Taking together on may suggest that correction of macrocirculatory para-
meters in treatment of shock might be insufficient as the uncorrected micro-
circulation can lead to the multiple organ dysfunction (Klijn et al., 2008).  
 
 
2.2.4. Microcirculation and IAH 
Whether or not the splanchnic blood flow is altered at increased IAP, especially 
at low degrees of IAH, is not known. Direct measurements of the blood flow or 
gut microcirculation are not applicable in everyday clinical practice. Verdant et 
al. demonstrated in a porcine model of severe sepsis that the severity and time 
course of microcirculatory changes are similar in the sublingual and gut regions 
(Verdant et al., 2009). Sublingual perfusion reflects blood flow in the splanch-
nic region due to the same embryonic origin (Kärner, 1997) and there are 
studies that support this hypothesis and show a good correlation between sub-
lingual and gastric CO2 pressures (Marik, 2001; Jin et al., 1998). Thus we 
believe that the sublingual assessment of the microcirculation may be relevant 
in this clinical setting. 
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2.3. Tissue metabolism and IAH 
Alterations in the organ microcirculation may lead to tissue anaerobic meta-
bolism. Microdialysis methodology has been successfully used in animal 
experiments to assess metabolic changes during IAH. Meier and co-workers 
used a rectus abdominis muscle (RAM) tissue microdialysis in a rat model of 
IAH (Meier et al., 2007). The RAM is surrounded by a tight sheet of fascia, 
which makes the muscle-fascia compartment relatively non-compliant. There-
fore, the pressure in the intra-abdominal cavity directly influences the muscle 
tissue and its perfusion. Recent animal experiments further support this notion 
and suggest that microdialysis of the RAM could serve as a readily accessible 
site for early detection of subclinical organ dysfunction (Benninger et al., 2012).  
 
 
2.3.1. Microdialysis methodology 
The microdialysis technique has been used for over 60 years. It is a minimally 
invasive sampling technique that is used for in vitro experiments and in vivo 
sampling of drugs, metabolites or endogenous substances from body fluids or 
from the extracellular fluid of selected tissues (Plock & Kloft, 2005).  
The microdialysis system consists of the microdialysis pump, the micro-
dialysis catheter and a microvial in which the probe is collected. The micro-
dialysis catheter consists of a thin dialysis tube with an inner diameter in the 
range of 0.15–0.3 mm and a semipermeable membrane at the tip of the catheter 
(Plock & Kloft, 2005). A schematic representation of a microdialysis system is 
shown in Figure 2. 
 
  
 
Figure 2. The microdialysis pump, the microdialysis catheter and a microvial in which 
the catheter is collected. On the tip of the catheter is a semipermeable membrane. Blue 
arrows indicate perfusate and red arrows dialysate. Ultrasound picture shows the micro-
dialysis catheter position in RAM tissue. 
 
 
catheter 
RAM 
Abdominal  
cavity 
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The perfusion fluid runs through inner tubing at a constant rate (0.5– 
5 µmol/min), passes through the membrane and is then transported through the 
outlet tubing and collected in a microvial. The diffusion process is dependent on 
the concentration gradient. 
 
 
2.3.2. Measured metabolites and their meaning 
The main endogenous compounds and metabolites measured in the extracellular 
fluid in muscle tissue are glucose, pyruvate, lactate, glycerol and glutamate. To 
great extent they characterize the state of aerobic metabolism of the tissue the 
samples are drawn.  
Glucose is the basic energy substrate for tissue functioning. It is broken 
down into pyruvate and then, through the Krebs cycle and oxidative phosphory-
lation, into water and carbon dioxide. This reaction requires the presence of 
oxygen. Under anaerobic conditions, the mitochondria are unable to oxidize 
pyruvate into water and carbon dioxide; therefore, the lactate concentration 
increases and thus lactate is a good marker of hypoxia. The tissue lactate-to-
pyruvate ratio (L/P ratio) reflects a reaction to changed oxygen and glucose 
supplies. It is a specific marker of anaerobic conditions (Birke-Sorensen & 
Andersen, 2010).  
Setälä et al. used microdialysis after microvascular flap transfer to monitor 
flap perfusion postoperatively. They found that tissue glucose and lactate 
concentrations, and especially their relationship (lactate-to-glucose ratio), can 
demonstrate the presence of ischaemia. A high lactate-to-glucose ratio can pre-
dict total or partial flap necrosis (Setälä & Gudaviciene, 2013). The mathe-
matical ratios L/P and lactate-to-glucose (L/G) are more sensitive for differen-
tiation between arterial and venous ischaemia than lactate, pyruvate or glucose 
values analysed alone (Setälä et al., 2004). Glycerol is most likely released from 
damaged cells due to ischaemia and tissue injury; it indicates the degradation of 
the glycerophospholipids of the cell membranes (Liu et al., 2010). 
Glutamate is a proteinogenic amino acid which may act as a neurotransmitter 
or metabolic substrate. Elevated extracellular concentrations may reflect excito-
toxicity and membrane breakdown (Korth et al., 2003). Glutamate release may 
be regarded as a surrogate of ongoing ischaemia (Kawada et al., 2005; Liu et 
al., 2010). 
Thus, all those metabolites are relevant to investigate metabolic derange-
ments in tissues where perfusion and/or oxygen supply is compromised.  
 
 
2.4. Summary of the review of the literature 
In summary, there is still a ‘grey zone’ in IAP, ranging from 12 mmHg to 18 
mmHg, where the clinical consequences of IAH are not clearly evident and 
treatment recommendations are inconsistent. This is in contrast to ACS, the 
clinical course of which is unequivocally detectable and where early causative 
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treatment is directly connected with a positive outcome. Thus, there is still no 
clear trigger at which level IAP active treatment should commence. The deterio-
ration of tissue metabolism in the abdominal area may occur well before the 
clinical signs of organ dysfunction related to IAH are evident. The present work 
was undertaken to clarify these issues. 
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3. AIMS 
 
The main aim of the present study was to investigate whether intra-abdominal 
hypertension is associated with alterations in tissue perfusion and metabolism. 
We focused on the sublingual microcirculation and abdominal rectus muscle 
metabolism as possible sites of reflection of splanchnic perfusion, which may 
have deteriorated first, already from moderate, Grade I-II IAH (IAP from 12 to 
18 mmHg).  
The specific aims were to test the following hypotheses:  
1. A mild and short-term increase in IAP during pneumoperitoneum compro-
mises blood flow in the splanchnic area, which is reflected in in micro-
circulatory changes in the sublingual area.  
2. Moderate and prolonged increases in IAP in critically ill patients cause 
alterations in the sublingual microcirculation and these changes are related to 
the severity of IAH.  
3. Mild and short-term increases in IAP during pneumoperitoneum lead to an 
accumulation of metabolites of anaerobic metabolism in the RAM, which 
reflects insufficient tissue perfusion in the abdominal area. 
4. An elevated IAP and a decreased abdominal perfusion pressure are as-
sociated with a prevalence of anaerobic metabolism in RAM tissue, thereby 
indicating abdominal hypoperfusion in critically ill patients. 
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4. MATERIALS AND METHODS 
 
To test the above hypotheses, four subsequent studies were conducted.  
Two prospective observational studies focused on microcirculatory changes: 
1. Mild and short-term increases in IAP in elective laparoscopic surgery 
patients (Study I) 
2. Moderate and prolonged increases in IAP in intensive care patients (Study 
II) 
 
Two prospective observational studies investigated abdominal rectus muscle 
tissue metabolism: 
3. Mild and short-term increases in IAP in elective laparoscopic surgery 
patients (Study III) 
4. Moderate and prolonged increases in IAP in intensive care patients (Study 
IV) 
All studies were approved by the University of Tartu Ethics Review Committee 
on Human Research (protocol nos. 170/T-11 28.04.2008 and 181/T-12 20.04. 
2009) and were conducted in accordance with the Helsinki Declaration. 
Informed consent was obtained from the patients or from the next-of-kin of ICU 
patients prior to inclusion in the study.  
 
 
4.1. Patients 
4.1.1. Mild and short-term increases in IAP (Studies I and III) 
Sixteen patients (14 females, 2 males, Table 1) scheduled for elective laparo-
scopic cholecystectomy were included in Study I, which investigated the sub-
lingual microcirculation, clinical data are presented in Table 2. SDF measure-
ments were performed as described below. The exclusion criteria were other 
laparoscopic surgery than cholecystectomy, refusal to participate, existing co-
morbidities (chronic or acute cardiac failure, ischaemic myocardial disease, 
coagulopathy, diabetes) and poor dental status.  
 
 
Table 1. Number of  patients enrolled in the studies of current work.  
Table 1 Microcirculation Tissue metabolism 
Short-term increase in IAP (laparoscopic 
surgery patients) 16 6 
Prolonged increase in IAP (ICU patients) 15 10 
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In Study III, six patients scheduled for elective laparoscopic gastric fundopli-
cation were included to investigate RAM tissue metabolism. The exclusion 
criteria were patient’s refusal to participate, BMI ≥ 32 kg/m2 and other surgery 
than laparoscopic gastric fundoplication. 
Pneumoperitoneum was part of the surgical procedure in both studies. IAP 
was held between 12 and 14 mmHg using an automated insufflator. 
 
 
4.1.2. Moderate and prolong increases in IAP (Studies II and IV) 
Consecutive patients admitted to the Department of General Intensive Care 
(ICU) at Tartu University Hospital were screened for inclusion in the study 
during the first three days of their treatment if they satisfied the following 
criteria:  
– ≥ 18 years of age 
– Measurement of IAP was possible (i.e., the urinary bladder catheter had been 
positioned) 
– At least one of the following risk factors for the development/presence of 
IAH at admission:  
- acute pancreatitis 
- liver failure with cirrhosis and ascites 
- gastrointestinal haemorrhage 
- use of vasopressors/inotropes 
- body mass index ≥ 30 kg/m2 
- PaO2/FiO2 ≤ 300 mmHg 
These risk factors for IAH were previously identified by Reintam Blaser et al. 
in the study conducted at the same department and, therefore, the case-mix is 
similar and the risk factors relevant (Reintam Blaser et al., 2011). 
In all screened patients, IAP was measured at intervals of at least 6 hours.  
If the patient had an IAP ≥ 12 mmHg for at least 12 hours, he/she was 
included in the study.  
Exclusion criteria were as follows: patient’s or next of kin’s refusal to parti-
cipate, thrombocytopenia or bleeding disorders, and BMI ≥ 32 kg/m2.  
Fifteen adult, mechanically ventilated patients (4 females, 11 males) were 
included. In all patients, the sublingual microcirculation was measured, while 
microdialysis probes for RAM tissue metabolism assessment were inserted in 
10 patients. 
 
4.2. Microcirculation measurements 
In 31 patients the sublingual microcirculation was visualized using an SDF 
imaging device (Microscan, Microvision Medical, Amsterdam, The Nether-
lands).  
The optical probe was applied to the sublingual mucosa after removal of 
saliva with a gauze swab. The videos were captured with sufficient precaution 
24 
to minimize motion and pressure artefacts; altogether, nine videos were 
recorded at one time point.  
Elective laparoscopic surgery patients (Study I) were enrolled to investigate 
the changes during short-term increases in IAP. Microcirculatory videos were 
recorded before administering anaesthesia, at least 15 minutes after the 
initiation of pneumoperitoneum and 1 hour after the end of pneumoperitoneum.  
Intensive care patients with IAH (Study II) were included. The SDF mea-
surements were performed at baseline and at 1, 2, 3 and 12 hours, and then 
twice daily for seven consecutive days or until extubation or death. The maxi-
mum number of recordings per patient was 17. For the final analysis, six time 
points were selected: 0, 12, 24, 48, 72 and 144 h. The SDF measurements in 
these patients were performed with the head of the bed elevated at least 30°. 
Microcirculatory videos, each 20 to 25 s, were analysed with the aid of 
specialized software by two different investigators who were unaware of the 
patient data.  
 
4.2.1. Microcirculatory values and indexes 
Microcirculatory videos were analysed using Automated Vascular Analysis 
(AVA 3.02, Academic Medical Centre, University of Amsterdam, The Nether-
lands) software. The microcirculation cut-off value for the vessels was 20 µm. 
AVA software gives the following two parameters automatically:  
1) Total vascular density (TVD) – total lengths of the small vessels divided by 
the total area of the image (De Backer et al., 2007).  
2) The De Backer Score – the density of the vessels is proportional to the 
number of vessels crossing arbitrary lines. In this score, three equidistant 
horizontal and vertical lines are drawn on the screen, and then the De 
Backer Score is calculated as the number of small vessels crossing the lines 
divided by the total length of the lines (De Backer et al., 2007). 
Subsequent parameters are derived after the subjective analysis of bloodflow in 
the microcirculatory videos. First, perfusion is evaluated as continuous (un-
interrupted flow for at least 15 seconds), sluggish (slow, but continuous flow), 
intermittent (no flow ≤ 50% of the time) or absent (no flow ≥ 50% of the time) 
(De Backer et al., 2007). The flow parameters are as follows:  
3) Proportion of perfused vessels (PPV), calculated as 100 × (total number of 
vessels – [no flow + intermittent flow]) divided by total number of vessels 
(De Backer et al., 2007).  
4) Perfused vessel density (PVD), calculated by multiplying the vessel density 
by the proportion of perfused vessels (De Backer et al., 2007). 
5) Microvascular flow index (MFI) – the bloodflow is characterized as absent, 
0, intermittent, 1, sluggish, 2 or normal, 3, in four separate quadrants, and 
then the mean is calculated (De Backer et al., 2007). 
6) Heterogeneity index (HI) – calculated as the highest site flow velocity 
minus the lowest site flow velocity, divided by the mean flow velocity of all 
sublingual sites (Trzeciak et al., 2007) (De Backer et al., 2007) 
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4.3. Microdialysis sampling 
Two hours before surgery (laparoscopic surgery patients, Study III) or at the 
beginning of the study (ICU patients, Study IV), the microdialysis catheter 
(CMA 60, Solna, Sweden) was inserted into the RAM tissue under local (2% 
lidocaine) or general (ICU patients) anaesthesia. The catheter was placed using 
ultrasound (Sonosite MicroMaxx, Bothell, WA, USA). The microdialysate 
perfusion rate was set at 0.3 l/min.  
In laparoscopic surgery patients the dialysate was collected hourly prior to 
pneumoperitoneum, during pneumoperitoneum and for 2 hours after the 
resolution of pneumoperitoneum.  
In ICU patients the sample specimens were collected at 26 time points: 
hourly for the first eight hours, every two hours for the next eight hours and 
then every four hours until the end of the study. The duration of the study was 
72 hours. 
The specimens were stored in a freezer at –80°C at Tartu University Hospital 
in Estonia and were sent in a single shipment at the end of both studies to 
Tampere University Hospital in Finland for additional analysis. The glucose, 
lactate, pyruvate, glycerol and glutamate contents of the microdialysates were 
measured with a CMA 600 analyser (Solna, Sweden). The L/P ratio and the L/G 
ratio were calculated. 
 
4.4. Statistical analysis 
The statistical analysis was performed using GraphPad Prism 5.02 (GraphPad 
Software, Inc., San Diego, CA, USA), STATISTICA 10 (Software System Stat-
soft, Inc., Tulsa, Oklahoma, USA) and StatsDirect 2.7.9 software (StatsDirect 
Ltd, Cheshire, UK). Normal distribution was determined by Kolmogorov-
Smirnov test.  
In Study I, repeated measurements analysis of variance with Tukey’s post 
hoc test was used to test the differences between the time points.  
In Study II, repeated measurements analysis of variance with Dunn’s post 
hoc test was used to test the differences between the time points in normally 
distributed data. Friedman´s test, along with Dunn’s post hoc test, was used for 
repeated comparisons of non-normally distributed data. For the correlation 
analysis, consecutive single measurements were used. The analysis was 
performed using STATISTICA 10 software; correlations within the subjects 
(using the method of Bland and Altman) were used because of the presence of 
multiple measurements from one patient (Bland, MJ, 1995). To eliminate the 
variation caused by the subjects, we performed an analysis of covariance to 
evaluate the relationship between the microdialysate contents and clinical 
variables, all of the patients being treated simultaneously as a categorical factor. 
Interobserver variability was calculated separately for each parameter by means 
of the Bland-Altman analysis for assessing agreement between two opinions 
(Bland & Altman, 1986) using StatsDirect 2.7.9 software. 
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In Study III, the Wilcoxon matched-pairs test (non-parametric) was used to 
test the median differences in paired data. 
In Study IV, for the RAM tissue metabolite concentrations (non-normally 
distributed data), Friedman’s test was used to test the change over the 
observation period. The patients’ clinical characteristics were averaged for 6 
time points (baseline and from 3 to 6 hours, from 7 to 12 hours, 12 to 24 hours, 
24 to 48 hours and 48 to 72 hours) and analysed using a repeated-measurements 
analysis of variance (normally distributed data) or Friedman’s test. Dunn’s test 
was used for the post hoc analysis. Correlation analyses were performed as in 
Study II. 
The data are presented as medians with interquartile ranges (IQRs) if not 
stated otherwise. Differences were considered significant at p ≤ 0.05. 
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5. RESULTS 
5.1 Clinical characteristics  
The main clinical characteristics of the study patients are shown in Table 2. All 
data are presented as medians (IQR). In laparoscopic surgery patients (Studies I, 
III), clinical data are given during the pneumoperitoneum period; in ICU 
patients (Studies II, IV) the clinical data describe the baseline situation. 
 
 
Table 2 Study I 
(during pneumo-
peritoneum) 
Study II 
(baseline) 
Study III 
(during pneumo-
peritoneum) 
Study IV 
(baseline) 
Patient cohort Laparoscopic cholecystectomy Critically ill 
Laparoscopic 
fundoplication Critically ill 
Patient numbers 
(F/M) 16 (14/2) 15 (4/11) 6 (3/3) 10 (1/9) 
Intervention SDF SDF Microdialysis Microdialysis 
Age (years) 52  (from 29 to 81) 
67 
(from 19 to 89) 
36  
(from 27 to 44) 
65  
(from 19 to 89) 
ASA/APACHE 
II score 2 (2–3) 28 (13–36) 2 (1–2) 29 (21–37) 
BMI kg/m2 29.7 (24.9–34.7) 28.5 (24.6–33.0) 26 (23–28) 26.9 (24.6–33.0) 
IAP (mmHg) 12.5 (12–13) 14.5 (12.5–16.0) 12 (12–13) 14.5 (12.5–17.8) 
MAP (mmHg) 86 (69–93) 90 (78–97) 77 (74–94) 83 (75–89) 
APP (mmHg) 73 (57–81) 72 (66–81) 65 (62–82) 70 (58–74) 
Heart rate 
(beats/min) 65 (55–70) 105 (86–117) 61 (56–73) 106 (94–121) 
Arterial lactate 
(mmol/l)  1.8 (1.3–3.4) 0.7 (0.6–1.5) 1.9 (1.3–3.75) 
Arterial pH 7.38 (7.34–7.47) 7.43 (7.37–7.45) 7.42 (7.34–7.47) 
Arterial BE 1.9 (-1.0–2.9) -1.1 (-2.8–0.1) 1.9 (-1.3–2.8) 
CVI  3 (0–4) 3.5 (0–4.3) 
SOFA 8 (6–9) 7 (6–9) 
 
F, female; M, male; SDF, Sidestream dark field imaging; ASA, American Society of 
Anesthesiologists (physical status classification system); APACHE, Acute Physiology 
and Chronic Health Evaluation (score); IAP, intra-abdominal pressure; MAP, mean 
arterial pressure; APP, abdominal perfusion pressure; CVI, cumulative vasopressor 
index (Trzeciak et al., 2008); SOFA, Sequential Organ Failure Assessment (score). 
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5.2. Arterial and intra-abdominal pressures in  
ICU patients (Studies II, IV) 
Changes in arterial and intra-abdominal pressures in intensive care patients are 
shown in Figures 3 and 4.  
The IAP decreased significantly in both studies (Figures 3A and 4A). While 
MAP remained unchanged (Figures 3B and 4B), the requirement for vaso-
pressors decreased significantly over the time period. APP increased in micro-
dialysis (Study IV) (p ≤ 0.03) (Figure 4C), but not in the microcirculation study 
(Study II).  
 
 
Figure 3. Changes in intra-abdominal (IAP, panel A), mean arterial (MAP, 
panel B) and abdominal perfusion pressures (APP, panel C) in intensive care 
(ICU) patients, included for assessment of the sublingual microcirculation study 
(n = 15, Study II). Data are presented as medians (IQR) and p-values indicate 
the significance of differences between the time points. 
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Figure 4. Changes in intra-abdominal (IAP, panel A), mean arterial (MAP, 
panel B) and abdominal perfusion pressures (APP, panel C) in intensive care 
unit (ICU) patients included for assessment of abdominal rectus muscle (RAM) 
tissue metabolism (n = 10, Study IV). Data are presented as medians (IQR), and 
p-values indicate the significance of differences between the time points. 
 
 
5.3. Sublingual microcirculation (Studies I, II) 
The dynamics of the sublingual microcirculation are shown in Figure 5. No 
significant changes were observed between the time points, neither in laparo-
scopic surgery nor in ICU patients. However, the overall density of micro-
vessels, if measured before laparoscopy (Figure 5, panel A, left graph) was 
significantly higher than in critically ill patients at inclusion in the study (Figure 
5, panel A, right graph; p ≤ 0.0001). In contrast, the proportion of perfused sub-
lingual microvessels (PPVs) was significantly better (p ≤ 0.0001) in critically ill 
patients, which may reflect their relatively better fluid status (Figure 5, panel 
C). The microvascular flow index (Figure 6, panel E, right graph) in ICU 
patients was also significantly higher (p ≤ 0.0001) and the flow was less hetero-
geneous (Figure 6, panel F; p = 0.02). 
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Figure 5. Dynamics of the sublingual microcirculation during the short-term 
increase in IAP (Study I) and during the moderate and prolonged increases of 
IAP (Study II). TVD indicates the total vascular density, PVD the perfused 
vessel density, PPV the proportion of perfused vessels. Data are presented as 
medians with the IQR and min-max. No differences were observed between the 
time points in both studies.  
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Figure 6. Dynamics of the sublingual microcirculation during the short-term 
increase in IAP (Study I) and during the moderate and prolonged increases of 
IAP (Study II). MFI indicates the microvascular flow index. Data are presented 
as medians with the IQR and min-max. No differences were observed between 
the time points in both studies.  
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The correlation analysis, adjusted for repeated measurements, revealed weak 
positive correlations between TVD and IAP, MFI and MAP and between MFI 
and APP (Table 3) in critically ill patients. The heterogeneity index was nega-
tively correlated with both MAP and APP; however, no correlation was 
detected between microcirculatory parameters and pH, lactate or the cumulative 
vasopressor index (CVI) (Trzeciak et al., 2008). 
 
 
Table 3. Main data of correlation analysis of sublingual microcirculatory 
parameters and mean arterial pressure, intra-abdominal pressure and abdominal 
perfusion pressure. The correlation is considered significant at p ≤ 0.05. Only 
significant correlations are shown.  
MAP IAP APP  
R p R p R p 
TVD 0.07 0.56 0.29 0.02   0.008 0.94 
MFI 0.23 0.05 –0.15 0.22   0.26 0.03 
Heterogeneity 
Index –0.29 0.01 0.02 0.86 –0.29 0.01 
 
TVD, total vascular density; MFI, microvascular flow index; MAP, mean arterial pres-
sure; IAP, intra-abdominal pressure; APP, abdominal perfusion pressure; R, correlation 
coefficient.  
 
 
5.4. RAM tissue metabolism during mild and  
short-term increase in IAP 
 (laparoscopic surgery patients, Study III) 
The dynamics of RAM tissue metabolites in laparoscopic surgery patients are 
shown in Figure 7. The tissue lactate (Figure 7B) and L/P ratio (Figure 7C) rose 
significantly after 1 hour of pneumoperitoneum; both levels returned to baseline 
after the cessation of pneumoperitoneum. Glucose (Figure 7A) showed a trend 
towards a decrease and glycerol (Figure 7C) rose during the pneumoperi-
toneum, but they did not reach the level of significance.  
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Figure 7. Dynamics of tissue metabolites in the abdominal rectus muscle during the 
short-term increase in IAP (laparascopic surgery, Study III, n = 6). Data are presented as 
medians (IQR). L/P ratio stands for lacatate-to-pyruvate ratio; L/G ratio for lactate-to-
glucose ratio.  
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5.5. RAM tissue metabolism during moderate and 
prolonged increases in IAP  
(intensive care patients, Study IV) 
The dynamics of RAM tissue metabolites in ICU patients are shown in Figure 
8. Significant changes were observed in tissue lactate (Figure 8B), L/P ratio 
(Figure 8C) and glutamate levels (Figure 8D). Tissue pyruvate elevated at the 
beginning of study but this change did not reach the significance (Figure 8B). 
L/G ratio level (Figure 8C) changed significantly (p = 0.003) during first 40 
hours but not then comparing the whole study period (p = 0.08). 
 
 
Figure 8. Dynamics of tissue metabolites in the abdominal rectus muscle during 
moderate and prolonged increases in IAP (ICU patients, n = 10, Study IV). Data are 
presented as medians (IQR). L/P ratio stands for lactate-to-pyruvate ratio; L/G ratio for 
lactate-to-glucose ratio. 
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The correlation analysis revealed an association between higher MAP and APP 
levels and lower tissue pyruvate concentrations and between the noradrenaline 
dose and RAM tissue pyruvate concentrations (Table 4). The elevated L/G ratio 
significantly correlated with a higher dose of noradrenaline (Table 4). There 
was also an association between elevated IAP levels and higher tissue glutamate 
concentrations (Table 4). RAM tissue glycerol concentrations did not change 
significantly during the study period; however, a simultaneous correlation ana-
lysis suggested that higher MAP and APP values were associated with lower 
glycerol concentrations (Table 4). 
 
 
Table 4. Correlation analysis between RAM metabolites and mean arterial pressure 
(MAP), intra-abdominal pressure (IAP), abdominal perfusion pressure (APP) nor-
adrenaline dose (µg/kg/min) and serum lactate concentration. The correlation is con-
sidered significant at p ≤ 0.05. R stands for correlation coefficient. 
 MAP IAP APP Nor-adrenaline 
R p R p R p R p 
Glucose -0.04 0.5 -0.1 0.3 0.02 0.9 0.1 0.1 
Pyruvate -0.3 0.0003 -0.08 0.4 -0.3 0.009 0.2 0.04 
Lactate -0.1 0.09 -0.09 0.4 -0.4 0.3 0.1 0.08 
L/P ratio 0.03 0.7 0.1 0.3 0.1 0.4 0.2 0.02 
L/G ratio 0.09 0.2 -0.08 0.4 0.05 0.6 0.6 0.0000 
Glycerol -0.2 0.008 -0.04 0.7 -0.2 0.03 0.008 0.9 
Glutamate 0.04 0.6 0.2 0.02 -0.02 0.8 -0.06 0.5 
 
 
We also performed correlation analyses between microcirculatory parameters 
(Study II) and RAM tissue metabolites (Study IV), measured concomitantly in 
the ICU patients, but did not observed any correlation between these para-
meters.  
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6. DISCUSSION 
 
The main finding of the present work is the prevalence of anaerobic metabolism 
in RAM tissue during grade I and II IAH. This result is supported by the results 
of tissue microdialysis during mild and moderate IAH in critically ill patients 
and during laparoscopic surgery. However, at the same time we could not 
demonstrate significant microcirculatory changes either in critically ill patients 
or during laparoscopic surgery. According to our results, the reason for anaero-
bic metabolism was not the alteration of the microcirculation. 
 
 
6.1. Microcirculation 
6.1.1. Mild and short-term increase in IAP (Study I) 
Microcirculation measurements during laparoscopic surgery showed that the 
short-term elevation of the IAP caused by pneumoperitoneum has no significant 
effect on the sublingual microcirculation. At the same time, the microcircu-
latory perfusion indices were relatively low at baseline and did not improve 
during the study period. Based on this study, we may speculate that a short-term 
moderate increase in IAP has no significant impact on the splanchnic circu-
lation. 
Patients in the current study were scheduled for elective surgery; they were 
relatively healthy and had no serious organ dysfunctions. Their baseline PPV 
was, however, only 59% and remained unchanged during the pneumope-
ritoneum. This could be explained by preoperative stress and concomitant 
adrenergic stimulation. A slight improvement in PPV during anaesthesia sup-
ports this theory. 
It is more likely that the relative hypovolaemia explains this observation. 
Patients were on a nil per os regimen from midnight prior to surgery. Con-
sidering that that they did not received intravenous fluids before the anaesthesia 
and many of them had surgery late in the morning or in the afternoon, 
dehydration could easily develop (Keane & Murray, 1986; Holte & Kehlet, 
2002). Although the patients received, on an average, 1550 ml of intravenous 
fluids during anaesthesia and the recovery period, this did not improve their 
perfusion indices at all. This may suggest that perioperative fluid management 
was suboptimal. 
Potential interference of arterial hypertension and smoking with the micro-
circulatory blood flow (Henriksson et al., 2012) could also be considered, but 
their effect is most likely negligible –  the patients did not smoke for at least 
two hours prior to anaesthesia, while hypertension was well treated and stable in 
all cases. 
Another factor to consider of microcirculation is volatile anaesthetics. 
Özarslan et al. have recently shown that isoflurane increases the microcircu-
latory flow after cardiopulmonary bypass in cardiac surgery patients, while 
desflurane has no effect and sevoflurane a negative effect on the micro-
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circulation (Özarslan et al., 2012). These effects were not evident, however, if 
microcirculatory values after the induction of anaesthesia were compared with 
baseline values; therefore, it is unlikely that the choice of volatile anaesthetic 
has influenced the results of the present study.   
 
 
6.1.2. Moderate and prolonged increases in IAP (Study II) 
In line with the Study I, the microcirculation measurements in the hetero-
geneous group of critically ill patients revealed that moderate and prolonged 
increases in IAP of up to 24 hours have only a negligible influence on the 
sublingual microcirculation.  
These patients had a median IAP of 14.5 mmHg measured in the supine 
position on entering the study entry and 10 out of 15 were in circulatory shock. 
It was somewhat unexpected that we did not detect significant alterations in the 
sublingual microcirculation. There are several explanations for this. First, it may 
appear that SDF technique used would detect only the changes in the most 
critical disorders. As tissue perfusion was already relatively good at study entry, 
no improvement can be substantiated by the further decrease in IAP. The 
relatively good microcirculation at study entry might also be regarded as 
indirect proof of an appropriate treatment of shock directed by macrocirculatory 
indices in our patients. Secondly, it could be that an IAP between 12 and 20 
mmHg is not associated with haemodynamic changes that are transmitted to 
produce detectable alterations in the peripheral circulation. Relatively stable 
mean arterial pressures throughout the study period support this claim. On the 
contrary, decreases in the lactate concentrations and vasopressor requirements 
would indicate improved tissue perfusion during the study. Another explanation 
for our findings is that our patients were not recruited immediately after 
admittance to the ICU but, on average, on day 2 of their stay. They had all 
undergone primary fluid-resuscitation, but 10 out of 15 patients still needed 
vasopressor infusions.  The main obstacles to earlier inclusion were logistical 
reasons, primary among which was difficulty in obtaining the desired informed 
consent, but, most importantly, the frequent development of IAH 24 to 72 hours 
after admission to the ICU, especially in cases of secondary IAH (Reintam et 
al., 2008), and therefore we believe the inclusion on the second day, on the 
average, is clinically relevant.  
Based on the correlation analysis, a higher IAP indicates higher vascular 
density, a result that is difficult to interpret, as it is the opposite of what was 
expected. One possible explanation is that direct compression of the vena cava 
causes hyperaemia in the upper vena cava system, which may result in 
redistribution of the bloodflow, and, accordingly, an increased TVD. 
The observed positive correlations between MFI, MAP and APP and nega-
tive correlations between HI, MAP and APP are more in accord with the idea 
that the microvascular bloodflow is impaired at lower levels of MAP and higher 
levels of IAP. The surprising result was that if we compared the previous two 
studies’ microcirculation results, the laparoscopic surgery sublingual perfusion 
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was significantly altered. The overall vascular density was higher in laparo-
scopic surgery patients, but the perfusion indices were significantly lower. A 
probable explanation for this is the preoperative stress and concomitant 
adrenergic stimulation during anaesthesia and surgery and suboptimal fluid 
therapy during the perioperative period. This is in accord with Holte & Kehlet’s 
conclusions (Holte & Kehlet, 2002). 
 
 
6.2. RAM tissue metabolism 
6.2.1. Mild and short-term increases in IAP (Study III) 
The main finding of the microdialysis measurements during the laparoscopic 
surgery is that a short-term elevation of the IAP caused by pneumoperitoneum 
is associated with metabolic changes in the abdominal wall muscle tissue. This 
indicates that anaerobic metabolism and, thereby, possible RAM tissue 
hypoperfusion occurs after very modest increases in IAP. Several studies have 
shown that an increase in the mean IAP is associated with adverse ICU 
outcomes (Malbrain et al., 2005; Reintam Blaser et al., 2011) However, the time 
course of IAP-related adverse events in humans is poorly understood. To 
address this issue, we used microdialysis-aided sample collections from the 
extracellular space of the RAM. The RAM is surrounded by a tight sheet of 
fascia, which makes the muscle-fascia compartment relatively non-compliant. 
Thus, the pressure in the intra-abdominal cavity is reflected to the muscle tissue 
and its perfusion. Meier and co-workers used a similar microdialysis approach 
in a rat model of IAH (Meier et al., 2007). They showed that during a 3-h period 
of IAP at 20 mmHg, the L/P ratio in the RAM tissue increased significantly, 
indicating ischaemia and energy failure.  
The results of the current laparoscopic surgery study, in which an increased 
L/P ratio in the RAM tissue of our patients was observed after only 1 hour of 
mild IAH, are surprising. However, it remains unclear whether the observed 
metabolic changes in RAM are directly related to the altered perfusion of intra-
abdominal organs, whether they are related to the clinical outcome and whether 
patient treatment should be modified based on these metabolic changes. The 
results indicate that IAP levels of 12 mmHg are associated with unfavourable 
metabolic conditions, and they therefore support the recommended IAH grading 
(Malbrain et al., 2006). Our results also support the European practice guide-
lines for pneumoperitoneum in laparoscopic surgery which state that IAP levels 
higher than 12 mmHg should be avoided and that the duration of the procedure 
must be kept as short as possible (Neudecker et al., 2002).  
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6.2.2. Moderate and prolonged increases in IAP (Study IV) 
The main finding of the microdialysis measurements during elevated IAP after 
initial resuscitation from shock was the prevalence of anaerobic metabolism in 
the RAM tissue indicates hypoperfusion in critically ill patients. Our finding of 
a negative correlation between APP, pyruvate and glycerol indicates a likely 
relevance of APP as a resuscitation end-point. The use of vasopressors 
contributed to keeping the MAP of our patients virtually unchanged and well 
above the target range of 75 mmHg. The fact that APP changed significantly 
and was associated with unfavourable changes supports the notion that IAP and 
APP should be considered when setting the targets for MAP and vasopressor 
therapy. 
In Study III, we observed that an IAP of 12–13 mmHg led to significant 
elevations of the L/P ratio during the short procedure. The investigations in 
critically ill patients corroborate findings in laparoscopic surgery patients: the 
L/P ratio and tissue lactate and glutamate are significantly elevated during IAH. 
When we compared the present results with the absolute values of RAM 
metabolites that are available from clinical studies, our patients appeared to 
have a markedly elevated L/P ratio and lactate and glycerol levels already at the 
beginning of the study (Table 5).  
Hörer and co-authors measured intraperitoneal lactate, pyruvate and glycerol 
in patients with an endovascular repair of a ruptured aortic aneurysm (Hörer et 
al., 2013). They observed an elevated L/P ratio and glycerol level (and IAP) in 
patients who were subjected to decompressive laparotomy because of clinically 
evident ACS. At the beginning of Study IV, 7 of the 10 patients were in shock. 
It is unclear from our microdialysis results whether the observed changes 
occurred because of shock resolution or because of dynamics in IAP and APP. 
The positive correlation between glutamate and IAP strongly indicates the 
importance of IAP in observed metabolite changes. 
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6.3. Methodological considerations  
6.3.1. Microcirculation studies  
There were several limitations of Studies I and II: first, the reproducibility and 
exactness of SDF imaging in assessments of the sublingual microcirculation 
have been questioned (Sallisalmi et al., 2012). We carefully followed the inter-
national consensus recommendations for this technique, such as sufficient 
training, more than one independent assessor of videos, etc. (De Backer et al., 
2007), but it still remains possible that this does not ensure a proper metho-
dology for research. Interobserver variability showed that one observer syste-
matically underestimated vascular density parameters and overestimated per-
fusion parameters or vice versa. We believe that using the median values in this 
case describes the real value in the best way. 
The absence of baseline videos (at admission to the ICU) and a control group 
could be regarded as a second limitation. For logistic reasons, we were not able 
record admission videos for all patients screened for inclusion. However, 
development of IAH 24 to 72 hours after ICU admission is common, especially 
in cases of secondary IAH (Reintam et al., 2008), and therefore we believe the 
inclusion on the second day, on the average, is clinically relevant. Due to the 
observational nature of both studies, a control group was not considered. The 
microcirculatory characteristics of healthy volunteers were recently published 
by Vellinga et al (Vellinga et al. 2012).  
The absence of cardiac output measurements for a comparative assessment 
of the systemic bloodflow is a third limitation of the study, especially in Study 
II. However, several studies have shown that relationships between the macro- 
and microcirculation in critically ill patients are surprisingly poor, especially 
after initial fluid resuscitation (De Backer et al., 2006; Arnold et al., 2012; 
Jhanji et al., 2010). Since the patients were enrolled in the microcirculation 
study after initial treatment of shock, we did not expect to see strong (IAP- 
related) associations between cardiac output and the sublingual microcirculation 
and cardiac output measurements were not implemented. 
 
 
6.3.2. Tissue metabolism studies  
The main limitations of both microdialysis studies include small sample size 
and microdialysis-related problems, specifically catheter displacement before or 
during laparoscopic surgery in two patients. The first limitation is expected, 
given that we are reporting these results as a pilot trial (Study III). The latter 
reflects the limitation of the method per se. Microdialysis is an invasive, 
relatively expensive and time-consuming procedure. 
The second limitation was the absence of control samples of non-abdominal 
origin, for example, from the extremities. It would have been desirable to 
address this question; however, due to ethical and cost concerns, we inserted 
only one MD catheter per patient. Indirect support of our findings is derived 
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from animal experiments by Meier and Benninger, who demonstrated that other 
tissues/locations are not influenced by IAP as fast as RAM is (Meier et al., 
2007; Benninger et al., 2012). Furthermore, the positive correlation between 
glutamate and IAP indicates the importance of IAP in observed metabolite 
changes. 
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7. CONCLUSIONS  
1. Mild and short-term increases in IAP in elective laparoscopic surgery 
patients is not associated with significant changes in the sublingual micro-
circulation. A low proportion of perfused vessels suggests some alteration of 
circulation during the perioperative period.  
2. Moderate and prolonged increases in IAP (IAH grades I and II (IAP 12 to 18 
mmHg)) cause mild microcirculatory changes in previously resuscitated ICU 
patients, lasting up to 24 hours. The correlation analysis indicates better 
microvascular bloodflow at higher MAP and APP levels.  
3. Mild and short-term increases in IAP during elective laparoscopic surgery 
are associated with unfavourable metabolic changes in the rectus abdominis 
muscle.  
4. Moderate and prolonged increases in IAP lead to RAM tissue anaerobic 
metabolism suggestive of hypoperfusion in critically ill patients. The corre-
lation analysis supports the concept of using APP as a primary endpoint of 
resuscitation in addition to MAP and IAP.  
 
The clinical implication of the present work is that mild to moderate IAH (IAP 
from 12 to 18 mmHg) cannot be ignored in critically ill patients. We support the 
use of APP as a primary endpoint of resuscitation in addition to MAP and IAP. 
The feasibility of RAM microdialysis as a diagnostic tool for early-stage tissue 
damage related to IAH requires additional investigation. Similarly, further 
studies are needed to clarify whether higher levels of IAP are associated with 
microcirculatory changes and whether preoperative fluid therapy would im-
prove the sublingual microcirculation in laparoscopic surgery patients.  
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SUMMARY IN ESTONIAN 
 
Kudede perfusioon ja metabolism intra-abdominaalse 
hüpertensiooniga patsientidel 
 
Intra-abdominaalne hüpertensioon (IAH) on püsiv või korduv intra-abominaalse 
rõhu (IAP) tõus üle 12 mmHg. IAH esineb umbes kolmandikul intensiivravi 
haigetel ja on seotud halvema elulemusega (Regueira et al., 2008; Santa-Teresa 
et al., 2012; Reintam et al., 2008). 
Tõusnud IAP põhjustab erinevaid muutuseid inimorganismis. Esmaseks IAH 
sümptom on enamasti langenud neerude funktsioon (Dalfino et al. 2008). Sa-
muti halvendab tõusnud IAP oluliselt südameveresoonkonna tööd, hingamis-
funktsiooni (Vegar-Brozovic et al., 2008). Sekundaarselt põhjustab tõusnud IAP 
ka ajusisese rõhu tõusu, mis omakorda võib viia ajuturse ja tõsise ajukahjustuse 
tekkele (Vegar-Brozovic et al. 2008). Samuti tekib IAH ajal erinevate põletiku-
mediaatorite vabanemine, mis võib kokkuvõtteks põhjustada hulgiorganpuudu-
likkuse tekke kriitilises seisundis haigel (Avraamidou et al. 2012; Rezende-Neto 
et al. 2002). 
IAH olulisus splanhikuse piirkonna verevarustuse muutuste ning soole 
mikrotsirkulatsiooni häirete juures on siiani kinnitust leidnud vaid loomkatsetes 
(Moore-Olufemi et al. 2005; Doty et al. 2002). Siiani puuduvad andmed selle 
kohta, kas ja kuidas mõjutab IAH kudede mikrotsirkulatsiooni ja metabolismi 
inimestel. 
 
Uurimistöö eesmärgid 
Uurimistöö peamiseks eesmärgiks oli teada saada, kas IAH põhjustab verevoolu 
ja ainevahetuse muutusi splanhikuspiirkonna kudedes. Keskendusime oma 
uuringutes keelealusele mikrotsirkulatsioonile ja kõhu sirglihase  metabolismile, 
sest mõlemad piirkonnad peegeldavad splanhikuspiirkonna verevarustust ning 
võiksid olla esimestena mõjutatud mõõdukast, I–II astme IAH-st (IAP vahe-
mikus 12–18 mmHg). 
Konkreetsed eesmärgid: 
1. Kas kerge ja lühiaegne IAP tõus pneumoperitoneumi ajal halvendab vere-
voolu splanhikuspiirkonnas, mis avaldub keelealuse piirkonna mikrotsirku-
latsiooni häirumises. 
2. Kas mõõdukas ja pikaaegne IAP tõus kriitilises seisundis haigetel põhjustab 
keelealuse piirkonna mikrotsirkulatsiooni halvenemise, mis on seotud IAH 
raskusastmega. 
3. Kas kerge ja lühiaegne IAP tõus pneumoperitoneumi ajal viib anaeroobse 
metabolismi produktide kuhjumisele kõhu sirglihases, mis väljendab eba-
piisavat kudede verevarustust. 
4. Kas tõusnud IAP ja langenud abdominaalne perfusioonirõhk (APP) on seo-
tud anaeroobse metabolism prevaleerumisega kõhu sirglihases, mis oma-
korda viitab kudede hüpoperfusioonile kriitilises seisundis haigetel. 
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Patsiendid ja metoodika 
Kokku viisime läbi 4 prospektiivset kliinilist uuringut. Kaks uuringut kesken-
dusid keelealuse piirkonna mikrotsirkulatsiooni muutustele: 1. kerge ja lühi-
aegne IAP tõus plaanilise laparoskoopilise kirurgia ajal (Uuring I); 2. mõõdukas 
ja pikaaegne IAP tõus intensiivravi haigetel (Uuring II). Kaks uuringut kesken-
dusid kõhu sirglihase metabolismile: 3. kerge ja lühiaegne IAP tõus plaanilise 
laparoskoopilise kirurgia aja (Uuring III); 4. mõõdukas ja pikaaegne IAP tõus 
intensiivravi haigetel (Uuring IV). 
Kokku kaasasime 37 patsienti. 
Mikrotsirkulatsiooni uurimiseks kasutasime Sidestream Dark Field (SDF) 
metoodikat, mis seisneb videomikroskoobiga mikrotsirkulatsiooni visualiseeri-
mises. SDF-metoodika võimaldab uurida erinevaid  kudesid, mis on kaetud 
õhukese epiteeli kihiga. Esimesesse uuringusse kaasasime plaanilised laparo-
skoopilise sapipõie kirurgia patsiendid, kellel oli operatsiooni ajal IAP lühiaeg-
selt tõstetud 12 kuni 14 mmHg-ni. Teise uuringusse kaasasime IAH intensiiv-
ravihaiged, kes olid hospitaliseeritud SA TÜK üldintensiivravi osakonda. 
Kudede metabolismi uurimiseks kasutasime mikrodialüüsi metoodikat, mis 
seisneb koevedeliku analüüsil. Kõikidele patsientidele sisestasime mikro-
dialüüsikateetri kõhu sirglihasesse ning määrasime koevedelikust hiljem glü-
koosi, püruvaadi, laktaadi, glütserooli, glutamaadi ning arvutasime laktaadi/ 
püruvaadi ja laktaadi/glükoosi suhte. Esimese uuringugrupi moodustasid plaa-
nilised laparoskoopilise fundoplikatsiooni patsiendid (IAP tõstetud operatsiooni 
ajal 12 kuni 14 mmHg-ni) ning teise grupi IAH-ga intensiivravi haiged. 
 
Tulemused 
Mikrotsirkulatsiooniuuringud: laparoskoopilise sapipõie kirurgia ajal ning IAH-
ga intensiivravi haigetel mikrotsirkulatsioon uuringu perioodi vältel oluliselt ei 
muutunud. Küll aga oli laparoskoopilise kirurgia patsientide keelealuste vere-
soonte perfusioon oluliselt halvem, kui eelnevalt vedelikravi saanud intensiiv-
ravi haigetel. Korrelatsioonanalüüsist selgus, et kõrgem keskmine arteriaalne 
vererõhk (MAP) ja kõrgem APP on mõlemad seotud parema mikrovaskulaarse 
verevoolu indeksiga ning verevoolu väiksema heterogeensusega. Koe meta-
bolismiuuringud: mõlemas uuringugrupis tekkis kõhu sirglihases tõusnud IAP 
ajal laktaat-püruvaadi suhte (L/P) oluline tõus, mis viitab anaeroobse metabo-
lismi prevaleerumisele. Intensiivravi haigete grupis esines lisaks laktaadi ja 
glutamaadi tõus, mis viitab tõsisele koekahjustusele. Intensiivravi haigete grupis 
teostasime ka korrelatsioonianalüüsid. Nendest ilmnes, et kõrgem MAP ja APP 
on seotud madalama püruvaadi- ja glütseroolikontsentratsiooniga RAM-koes. 
Samal ajal kõrgem noradrenaliini annus viitas tõusnud püruvaadi kontsentrat-
sioonile; kõrgemale laktaat-glükoosi suhtele, mis viitab isheemia olemasolule 
ning ka tõusnud L/P suhtele. Tõusnud IAP korreleerus kõrgema glutamaadi 
sisaldusega. Kõik eelnev kinnitab, et IAH ajal prevaleeruvub kõhu sirglihases 
anaeroobne metabolism ning see võiks omakorda viidata kudede hüpoperfu-
sioonile. 
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Uurimuse järeldused 
1. Kerge ja lühiaegne IAP tõus pneumoperitoneumi ajal ei ole seotud keele-
aluse piirkonna mikrotsirkulatsiooni muutuste tekkega. Vähese verevooluga 
veresoonte suur osakaal võiks viidata vereringe mõningasele halvenemisele 
perioperatiivses perioodis. 
2. Mõõdukas ja pikaaegne IAP (I ja II astme IAH (IAP vahemikus 12–18 
mmHg)) põhjustab kergeid mikrotsirkulatsiooni muutusi eelnevalt vedelik-
ravi saanud kriitilises seisundis haigetel. Korrelatsioonanalüüsid viitavad 
sellele, et mikrovaskulaarne verevool on seda parem, mida kõrgem on kesk-
mine arteriaalne vererõhk (MAP) ja APP. 
3. Kerge ja lühiaegne IAP tõus plaanilise laparoskoopilise fundoplikatsiooni 
ajal viib kõhu sirglihase metabolismi halvenemisele. 
4. Mõõdukas ja pikaaegne IAP viib anaeroobse metabolismi prevaleerumisele 
kõhu sirglihases kriitilises seisundis haigetel, mis omakorda viitab võima-
likule kudede hüpoperfusioonile. Korrelatsioonanalüüsid toetavad põhi-
mõtet, et APP normaliseerimine peaks olema esmaseks ravieesmärgiks 
lisaks senisele MAP-ile ja IAP-le. 
Antud uurimuse peamine kliiniline olulisus on see, et kerget kuni mõõdukat 
IAH ei tohi kriitilises seisundis haigetel ignoreerida. Piisava APP tagamine on 
meie tulemuste põhjal oluline osa selliste haigete esmasest ravist. 
Kindlasti on vajalikud edasised uuringud selgitamaks, kas kliinilises prakti-
kas oleks kõhu sirglihase mikrodialüüs varajane diagnostiline vahend IAH-ga 
seotud koekahjustuse tekke identifitseerimisel. Samuti on vajalikud täpsemad 
uuringud selleks, et selgitada kas kõrgemad IAP tasemed on seotud mikrotsirku-
latsiooni muutustega ning kas operatsioonieelne vedelikravi parandab keelealust 
mikrotsirkulatsiooni laparoskoopilise kirurgia haigetel. 
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